Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept
- PMID: 28902675
- PMCID: PMC5726912
- DOI: 10.1097/ALN.0000000000001878
Malignant Hyperthermia in the Post-Genomics Era: New Perspectives on an Old Concept
Abstract
This article reviews advancements in the genetics of malignant hyperthermia, new technologies and approaches for its diagnosis, and the existing limitations of genetic testing for malignant hyperthermia. It also reviews the various RYR1-related disorders and phenotypes, such as myopathies, exertional rhabdomyolysis, and bleeding disorders, and examines the connection between these disorders and malignant hyperthermia.
Conflict of interest statement
Authors declared no conflict of interest.
Figures

Comment in
-
A Primer for Diagnosing and Managing Malignant Hyperthermia Susceptibility.Anesthesiology. 2018 Jan;128(1):8-10. doi: 10.1097/ALN.0000000000001879. Anesthesiology. 2018. PMID: 28926348 No abstract available.
References
-
- MacLennan DH, Phillips MS. Malignant hyperthermia. Science. 1992;256:789–94. - PubMed
-
- Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta. 2011;1813:948–64. - PubMed
-
- Rosero EB, Adesanya AO, Timaran CH, Joshi GP. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology. 2009;110:89–94. - PubMed
-
- Larach MG, Brandom BW, Allen GC, Gronert BA, Lehman EB. Cardiac arrests and deaths associated with malignant hyperthermia in North America from 1987 to 2006: A report from The North American Malignant Hyperthermia Registry of the United States. Anesthesiology. 2008;108:603–11. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical